Williams AD, Ruth K, Shaikh SS, Vasigh M, et al. Should patients with hormone receptor-positive, HER2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib? Cancer 2023 Nov 29. doi: 10.1002/cncr.35136.
PMID: 38018862